Carbapenemase

Part of speech: noun

Definitions

1. An enzyme produced by certain bacteria that breaks down carbapenem antibiotics, rendering them ineffective and contributing to antibiotic resistance
2. A bacterial enzyme capable of hydrolyzing carbapenem-class antibiotics, leading to resistance against these drugs used to treat serious infections
3. A microbial protein that deactivates carbapenem antibiotics by catalyzing their breakdown, often found in resistant bacterial strains causing clinical challenges

Etymology: The term emerged in the realm of microbiology and medicine during the late 20th century, as scientists identified a new class of enzymes that could break down carbapenems, a powerful group of beta-lactam antibiotics. These enzymes, initially noted in resistant bacterial strains, posed a significant challenge to treating infections, prompting researchers to coin a specific name for the culprit behind this resistance. Breaking down the word reveals its components: "carbapenem" refers to a subclass of beta-lactam antibiotics characterized by a carbapenem ring structure, crucial for their broad-spectrum activity. The suffix "-ase" is a common ending in biochemistry used to denote enzymes, proteins that catalyze specific chemical reactions. Thus, the whole term designates an enzyme that hydrolyzes carbapenem antibiotics, rendering them ineffective. The root "carbapenem" itself is a blend of "carba-" indicating the presence of a carbon atom replacing a sulfur atom in the molecule’s structure, and "-penem," a suffix used to classify this family of antibiotics related to penicillins. The suffix "-ase" comes from the French adaptation of the Latin "-asum," standard in naming enzymes since the late 19th century, following the discovery of amylase and other similar catalysts. First recorded in scientific literature in the 1990s, the word gained prominence as carbapenem-resistant bacteria became a critical concern in clinical settings worldwide. The discovery of carbapenemases marked a turning point in understanding bacterial resistance mechanisms, underscoring the ongoing arms race between antibiotic development and microbial evolution.